DK0674718T3 - Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi - Google Patents

Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi

Info

Publication number
DK0674718T3
DK0674718T3 DK93921375T DK93921375T DK0674718T3 DK 0674718 T3 DK0674718 T3 DK 0674718T3 DK 93921375 T DK93921375 T DK 93921375T DK 93921375 T DK93921375 T DK 93921375T DK 0674718 T3 DK0674718 T3 DK 0674718T3
Authority
DK
Denmark
Prior art keywords
hiv
therapy
monitoring
identifying individuals
individuals infected
Prior art date
Application number
DK93921375T
Other languages
Danish (da)
English (en)
Inventor
Fred I Chasalow
Original Assignee
Supergen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Supergen Inc filed Critical Supergen Inc
Application granted granted Critical
Publication of DK0674718T3 publication Critical patent/DK0674718T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK93921375T 1992-09-08 1993-09-07 Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi DK0674718T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US94092792A 1992-09-08 1992-09-08
US08/065,062 US5464740A (en) 1992-09-08 1993-05-20 Diagnositc agent and methods for identifying HIV infected individuals and monitoring their therapy
PCT/US1993/008370 WO1994005814A1 (en) 1992-09-08 1993-09-07 Diagnostic agent and methods for identifying hiv infected individuals and monitoring their therapy

Publications (1)

Publication Number Publication Date
DK0674718T3 true DK0674718T3 (da) 2001-12-10

Family

ID=26745162

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93921375T DK0674718T3 (da) 1992-09-08 1993-09-07 Fremgangsmåde til identifikation af individer smittet med HIV og overvågning af deres terapi

Country Status (12)

Country Link
US (2) US5464740A (de)
EP (1) EP0674718B1 (de)
KR (1) KR950703658A (de)
AT (1) ATE204335T1 (de)
AU (1) AU678990B2 (de)
BR (1) BR9307176A (de)
CA (1) CA2143872A1 (de)
DE (1) DE69330611T2 (de)
DK (1) DK0674718T3 (de)
ES (1) ES2163411T3 (de)
HU (1) HUT74412A (de)
WO (1) WO1994005814A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5780222A (en) * 1995-04-10 1998-07-14 Alpha Therapeutic Corporation Method of PCR testing of pooled blood samples
US8615409B1 (en) 2005-04-15 2013-12-24 Recovery Data-Connect, L.L.C. System and method for identification, perfection, collection, and valuation of third-party claims including subrogation claims
ES2644334T3 (es) 2014-04-04 2017-11-28 Idcgs Clinica De Diagnosticos Medicos Biomarcadores para evaluar el VIH
CN110988178A (zh) * 2019-12-12 2020-04-10 谱尼测试集团股份有限公司 一种磷酸胆碱的高效液相色谱检测方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
US5122371A (en) * 1986-12-09 1992-06-16 Chaslow Fred I Biologically active agent having antihypertensive activity in mammals
US5028438A (en) * 1986-12-09 1991-07-02 Long Island Jewish Medical Center Biologically active agent having anti-hypertensive activity in mammals
CA2004410A1 (en) * 1988-12-02 1990-06-02 Fred I. Chasalow Diagnostic assay for breast cancer in human female patients

Also Published As

Publication number Publication date
WO1994005814A1 (en) 1994-03-17
US5643716A (en) 1997-07-01
CA2143872A1 (en) 1994-03-17
AU678990B2 (en) 1997-06-19
ES2163411T3 (es) 2002-02-01
BR9307176A (pt) 1999-05-11
HUT74412A (en) 1996-12-30
EP0674718B1 (de) 2001-08-16
ATE204335T1 (de) 2001-09-15
US5464740A (en) 1995-11-07
KR950703658A (ko) 1995-09-20
AU4848993A (en) 1994-03-29
EP0674718A1 (de) 1995-10-04
DE69330611D1 (de) 2001-09-20
EP0674718A4 (de) 1999-04-14
DE69330611T2 (de) 2001-11-29
HU9500695D0 (en) 1995-04-28

Similar Documents

Publication Publication Date Title
SE8206168D0 (sv) Preparations and process for preparation thereof
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
DE3679708D1 (de) Verfahren zur verleihung von immuntoleranz gegen ein spezifisches antigen.
ES2013226A4 (es) Metodo y composiciones proveiendo quimicoluminiscencia mejorada de 1,2-dioxanos
DE69027812D1 (de) Verfahren zur Zurichtung eines verbesserten Western-Blott-Immuntestverfahrens
FI895959A7 (fi) Koostumus, diagnostinen käyttöpakkaus ja menetelmä vasta-aineiden nope aksi toteamiseksi
AU5948090A (en) Silver enhanced gold-labelled immuno assay method
DE3788762D1 (de) Verfahren zur Bestimmung von physiologisch wirksamen Substanzen.
FI873553A7 (fi) HIV-infektioiden hoitoon ja diagnostisointiin käyttökelpoisia monoklonaalisia vasta-aineita ja peptidejä
AU2314088A (en) Method for rapid and sensitive detection of igm retroviral antibodies
DE3889279D1 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B.
ATE54757T1 (de) Verfahren zum nachweis von htlv-iii neutralisierenden antikoerpern in sera.
FI854627A7 (fi) Menetelmä ja reagenssi plasmassa, seerumissa tai kokoveressä olevan vapaan tyroksiinin kvantitatiiviseksi määrittämiseksi.
DE69330611D1 (de) Verfahren zur identifikation von mit hiv infizierten personen und zur überwachung ihrer therapie
FI881355A7 (fi) Määritysmenetelmä hepatiittiantigeenien ja AIDS-vasta-aineiden toteamiseksi.
EP0293827A3 (de) Probe für Leishmaniosis
ES2094124T3 (es) Ensayo-inmunologico de anticuerpos contra hiv.
IT8622560A0 (it) Polipeptidi immunologicamente attivi utili per la preparazione di vaccini antimalaria e di kitsdiagnostici per la determinazione di anticorpi antisporozoita.
ATE80226T1 (de) Verfahren zum nachweis von einer infektion oder entzuendung des harnbezueglichen tractus.
Boufassa et al. HEMOCO: a French prospective study of hemophiliacs infected by human immunodeficiency virus type 1 (HIV-1)
DK0505414T3 (da) Eliminering af aktiverede lymfocytter
DE3578742D1 (de) Verfahren zur bestimmung der antikoerper vom herpes-simplex-virus.
DE69026076D1 (de) Exkretorische/sekretorische antigene des bandwurms (cysticercus cellulosae) zur verwendung in der immundiagnostik und der impfstoffbereitung
NO870461D0 (no) Reagens for paavisning av antistoff mot virusantigener.
DE69023500D1 (de) Verfahren zum nachweis von antikörpern gegen streptokinase.